GGrantIndex
Sort

64,565 grants matching drug discovery

Measurement of Cancer-Associated Biomarker Proteins in Complex Biological Samples

$1,594,648
Amanda G Paulovich · Fred Hutchinson Cancer Research Center · RC2 · FY2010 · CA

Development of a5* nAChR positive allosteric modulators for tobacco dependence

$1,593,145
Paul J Kenny · Scripps Research Institute, The · R01 · FY2011 · DA

Defining the universal genomic language of hallmarks in tumor development

$1,593,000
Felix Dietlein · Boston Children'S Hospital · DP2 · FY2023 · CA

MEDICINAL CHEMISTRY FACILITY

$1,590,237
Gregg Pioske · University Of Minnesota · N01 · FY2015 · HD

NHGRI/DIR Technology Transfer Program

$1,590,131
Daniel Kastner · National Human Genome Research Institute · ZIK · FY2011 · HG

Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies

$1,589,329
Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2021 · AI

SPORE in Ovarian Cancer

$1,589,106
Ie-Ming Shih · Johns Hopkins University · P50 · FY2022 · CA

Rare Disease Network for Myasthenia Gravis

$1,588,974
Henry J Kaminski · George Washington University · U54 · FY2022 · NS

NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE

$1,588,410
Nathan S. Kline Institute For Psych Res · P01 · FY2002 · AG

Development and Preclinical Applications of Pancreatic Adenocarcinoma Models

$1,588,248
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease

$1,587,671
Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2022 · AG

Expression Genetics in Drug Therapy

$1,587,669
Wolfgang Sadee · Ohio State University · U01 · FY2014 · GM

Prostate Cancer Bone Metastasis Biology and Targeting

$1,587,650
Michael R Freeman · Cedars-Sinai Medical Center · P01 · FY2019 · CA

Interventional approaches for restoring vision

$1,587,484
Anand Swaroop · National Eye Institute · ZIA · FY2016 · EY

Inhibition Of Renal Injury

$1,587,394
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Expression Genetics in Drug Therapy

$1,586,888
Wolfgang Sadee · Ohio State University · U01 · FY2012 · GM

Malaria Drug Resistance and Disease Virulence

$1,585,344
Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease

$1,585,167
Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2024 · AG

Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies

$1,584,870
Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2023 · AI

Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease

$1,584,706
Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2023 · AG

Development of Pre-Erythrocytic Malaria Vaccines and antibodies

$1,584,649
Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Genetic susceptibility to unrelated donor stem cell transplant-related mortality

$1,584,230
Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2010 · HL

Development of a human hepatocyte predictive pharmacology and toxicology system.

$1,584,146
Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2013 · DK

Functional Analysis of Novel Genes in Eye Development and Vision

$1,584,030
Graeme J Wistow · National Eye Institute · ZIA · FY2025 · EY

Role of C-EBP transcription factors in cell growth and tumorigenesis

$1,583,541
Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA